A new dataset for predicting antigen-antibody interactions, published in the prestigious machine learning conference NeurIPS 2023, will help accelerate AI drug discovery KYOTO, Japan--(BUSINESS WIRE)- ...
SEATTLE, May 16, 2023 — A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions, and Lawrence Livermore National Laboratory (LLNL) today ...
MONTREAL--(BUSINESS WIRE)--Ability Biologics (“Ability”) is proud to announce a new partnership with Mila - Quebec Artificial Intelligence Institute. This partnership will bring together Mila’s ...
Scientists from the University of North Carolina have recently conducted computational modeling studies to predict the structure and immune escape ability of spike receptor-binding domain (RBD) of the ...
Antibody reactome profiling is a powerful approach for analyzing antibody-antigen interactions at scale, offering a comprehensive view of an individual’s immune history and current immune status. This ...
In a recent article published in the Science Immunology Journal, researchers probed for antibody binding against all seven human coronaviruses (hCoVs) and 49 animal coronaviruses (aCoVs) represented ...
Genetic polymorphisms of metabolizing enzymes and transporters correlate with pharmacokinetics (PK) and pharmacodynamics (PD) of amrubicin. Background: CTL-associated antigen 4 (CTLA4) is a ...
GEN recently spoke with Ryan Bomgarden, PhD, senior R&D manager at Thermo Fisher Scientific, about the many advances being made in understanding protein-protein interactions as well as what the future ...